Back to companies
Inhibikase Therapeutics, Inc.
IKTUSNASDAQPharmaceuticals & HealthcareInhibikase Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$52.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API